Skip to main content

Day: August 12, 2020

National Vision Launches its First-Ever Philanthropic Impact Report

DULUTH, Ga., Aug. 12, 2020 (GLOBE NEWSWIRE) — National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”), one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, has launched its first-ever philanthropic impact report, A World Worth Seeing, which details how the Company – including through the generosity of its associates and network of doctors – is transforming the lives of people in the United States and around the world.“This is our first-ever attempt to codify a comprehensive overview of National Vision’s philanthropic programs and impact,” said Reade Fahs, Chief Executive Officer at National Vision. “We have always thought of ourselves as a fast growing social business providing low cost healthcare to uninsured Americans and those living on very tight budgets. And,...

Continue reading

Rackspace Technology Global Announces Tender Offer for Up to $600.0 million of its 8.625% Senior Notes due 2024

SAN ANTONIO, Aug. 12, 2020 (GLOBE NEWSWIRE) — Rackspace Technology Global, Inc. (NASDAQ:RXT) (the “Company”) today announced that it is commencing a tender offer (the “Tender Offer”) to purchase for cash up to $600.0 million aggregate principal amount (the “Tender Cap”) of its approximately $1,120.2 million outstanding 8.625% Senior Notes due 2024 (the “Notes”).The Tender Offer is subject to the terms and conditions set forth in the Offer to Purchase, dated August 12, 2020, relating thereto (the “Offer to Purchase”).The Notes and other information relating to the Tender Offer are listed in the table below. The Offer to Purchase more fully sets forth the terms of the Tender Offer.(1) Per $1,000 principal amount of Notes and excluding accrued and unpaid interest, which will be paid in addition to the Total Consideration or Tender...

Continue reading

Rogers celebrates Ted Rogers Scholarship Class of 2020 in Quebec on International Youth Day

Empowering Quebec youth through education, 32 scholarships for fall 2020Over a quarter of a million dollars in scholarships awarded to hundreds of Quebec students since 2017MONTREAL, Aug. 12, 2020 (GLOBE NEWSWIRE) — Today, as the United Nations marks International Youth Day 2020 and the power of engaging young people to make a difference, Rogers Communications celebrates the Ted Rogers Scholarship Class of 2020 in Quebec.  Thirty-two students in the region will begin their post-secondary studies with the scholarship program this fall. Building on the legacy of Rogers founder Ted Rogers, these scholarships help aspiring young leaders overcome barriers to accessing post-secondary education. In a year where high school graduations were marked with yard signs and virtual proms instead of commencement speeches and cap-and-gown celebrations,...

Continue reading

Rogers celebrates Ted Rogers Scholarship Class of 2020 in Alberta, Saskatchewan and Manitoba on International Youth Day

Empowering youth through education, 33 scholarships in Prairies for fall 2020$470,000 in scholarships awarded to 75 students across the region since 2017CALGARY, Alberta, Aug. 12, 2020 (GLOBE NEWSWIRE) — Today, as the United Nations marks International Youth Day 2020 and the power of engaging young people to make a difference, Rogers Communications celebrates the Ted Rogers Scholarship Class of 2020 in Alberta, Saskatchewan and Manitoba.  33 students in the region will begin their post-secondary studies with the scholarship program this fall. Building on the legacy of Rogers founder Ted Rogers, these scholarships help aspiring young leaders overcome barriers to accessing post-secondary education. In a year where Canadian high school graduations were marked with yard signs and virtual proms instead of commencement speeches and cap-and-gown...

Continue reading

Rogers celebrates Ted Rogers Scholarship Class of 2020 in Atlantic Canada on International Youth Day

Empowering Atlantic youth through education, more than 33 scholarships for fall 2020More than $500,000 in scholarships awarded to 90 Atlantic Canadian students since 2017HALIFAX, Nova Scotia, Aug. 12, 2020 (GLOBE NEWSWIRE) — Today, as the United Nations marks International Youth Day 2020 and the power of engaging young people to make a difference, Rogers Communications celebrates the Ted Rogers Scholarship Class of 2020 in Atlantic Canada.  More than 33 students in the region will begin their post-secondary studies with the scholarship program this fall. Building on the legacy of Rogers founder Ted Rogers, these scholarships help aspiring young leaders overcome barriers to accessing post-secondary education. In a year where Canadian high school graduations were marked with yard signs and virtual proms instead of commencement speeches...

Continue reading

Rogers celebrates Ted Rogers Scholarship Class of 2020 in the National Capital Region on International Youth Day

Empowering Ottawa youth through education, 10 scholarships for fall 2020$6.5 million in scholarships awarded to Canadian students since 2017OTTAWA, Aug. 12, 2020 (GLOBE NEWSWIRE) — Today, as the United Nations marks International Youth Day 2020 and the power of engaging young people to make a difference, Rogers Communications celebrates the Ted Rogers Scholarship Class of 2020 in the National Capital Region. Ten deserving students in the region will begin their post-secondary studies with the scholarship program this fall. Building on the legacy of Rogers founder Ted Rogers, these scholarships help aspiring young leaders overcome barriers to accessing post-secondary education. In a year where Canadian high school graduations were marked with yard signs and virtual proms instead of commencement speeches and cap-and-gown celebrations,...

Continue reading

Akari Therapeutics Announces Successful End-of-Phase II Meeting With FDA to Initiate Pivotal Phase III Study for Treatment of Bullous Pemphigoid With Nomacopan

Phase III randomized placebo-controlled study in moderate to severe bullous pemphigoid (BP) patients with a primary endpoint of complete disease remission on minimal oral corticosteroids (OCS) agreed to with the FDA. Treatment arms will be tapered to minimal OCS and an important secondary endpoint is reduction in cumulative OCS on nomacopan as high dose OCS are regarded as unsafe in this vulnerable patient population. BP Phase III trial expected to start H1 2021 Nomacopan has been granted orphan drug designation by the FDA and the EMA for the treatment of BP Nomacopan has potential to replace long term steroid treatment (standard of care) in BP, which has multiple adverse effects in this elderly and frail populationNEW YORK and LONDON, Aug. 12, 2020 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company...

Continue reading

Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) and Provides Progress Update on COVID-19 antibody tests

IRVINE, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for Biomerica’s second U.S. patent pertaining to the Company’s InFoods® technology platform that offers a revolutionary new way to treat patients suffering from Irritable Bowel Syndrome (IBS) and other gastrointestinal diseases. Specifically, this allowed application #16/385,322 contains numerous claims that broadly cover the method that enables physicians to identify patient specific foods (e.g. pork, milk, shrimp, broccoli, chickpeas, etc.), that when removed may alleviate or improve an individual’s IBS symptoms, such as constipation, diarrhea, bloating, severe cramping, pain and indigestion.The InFoods® diagnostic guided IBS therapy is in clinical...

Continue reading

Cassava Sciences Announces Second Quarter 2020 Financial Results and Mid-year Business Review

– Final Clinical Results of a Phase 2b Study in Alzheimer’s Disease with Lead Drug Candidate, PTI-125, Expected to be Announced September 2020 – – SavaDx Demonstrates Direct Evidence of Target Engagement & Treatment Effects –– Open-label Study Of PTI-125 Reaches >50% Enrollment –AUSTIN, Texas, Aug. 12, 2020 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced financial results for the second quarter ended June 30, 2020 and provided a mid-year business review.Financial UpdateFor the second quarter ended June 30, 2020, net loss was $1.1 million, or $0.05 per share, compared to a net loss of $1.1 million, or $0.06 per share, for the same period in 2019. Net cash used in operations was $2.0 million during...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.